| Bioactivity | Gavestinel (GV 150526) is a selective and potent the glycine site of the NMDA receptor antagonist. Gavestinel has neuroprotectant effects[1]. |
| Name | Gavestinel |
| CAS | 153436-22-7 |
| Formula | C18H12Cl2N2O3 |
| Molar Mass | 375.21 |
| Appearance | Solid |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | 4°C, protect from light *In solvent : -80°C, 6 months; -20°C, 1 month (protect from light) |
| Reference | [1]. J F Hoke, et al. Pharmacokinetics of a glycine site antagonist (gavestinel) following multiple dosing in patients with acute stroke. Eur J Clin Pharmacol. 2000 Feb-Mar;55(11-12):867-72. |
Gavestinel
CAS: 153436-22-7 F: C18H12Cl2N2O3 W: 375.21
Gavestinel (GV 150526) is a selective and potent the glycine site of the NMDA receptor antagonist. Gavestinel has neurop
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.